Doula Combined Latent Phrase Epidural Analgesia in Primiparous Women (DCLEAP)

May 26, 2009 updated by: Nanjing Medical University

In Combination of Doula and Epidural Analgesia in the Latent Phrase of Labor in Primiparous Women

Accumulating evidence indicated that neuraxial analgesia in the latent phase of the first stage of labor would be an effective and safe health care procedure for nulliparas. Doulas, women with labor experience trained for parturients, is a new way to alleviate the psychological stress from the laboring pain. Previous data in our study showed that doula accompany is a good method in shortening the progress of labor used in the active phrase of the first stage of labor, and decreasing the rate of cesarean delivery. Investigators hypothesized that doula combined neuraxial (epidural) analgesia in the latent phrase would be a superior means for effective pain relief, decreased rate of cesarean section, and shortened duration of labor.

Study Overview

Study Type

Interventional

Enrollment (Actual)

500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Jiangsu
      • Nanjing, Jiangsu, China, 210004
        • Nanjing Maternal and Child Health Care Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Nulliparous women
  • > 18 years and < 45 years
  • Spontaneous labor
  • Analgesia request

Exclusion Criteria:

  • Allergy to opioids, a history of the use of centrally-acting drugs of any sort, chronic pain and psychiatric diseases records
  • Participants younger than 18 years or older than 45 years
  • Those who were not willing to or could not finish the whole study at any time
  • Using or used in the past 14 days of the monoamine oxidase inhibitors;
  • Alcohol addictive or narcotic dependent patients were excluded for their influence on the analgesic efficacy of the epidural analgesics
  • Subjects with a nonvertex presentation or scheduled induction of labor
  • Cervical dilation was 4.0 cm or greater before performing epidural puncture and catheterization

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 1
Doula combined epidural analgesia in the latent phase of first stage of labor
Doula combined epidural analgesia in the latent phase of first stage of labor in primiparas
Sham Comparator: 2
Epidural analgesia in the latent phase of the first stage of labor without doula accompany
Epidural analgesia in the latent phase of first stage of labor without doula accompany in primiparas

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Rate of cesarean delivery
Time Frame: Analgesia initiation (0 h) to completion of vaginal delivery (4-7 h)
Analgesia initiation (0 h) to completion of vaginal delivery (4-7 h)

Secondary Outcome Measures

Outcome Measure
Time Frame
Rate of instrumental delivery
Time Frame: Analgesia initiation (0 h) to successful vaginal delivery (4-7 h)
Analgesia initiation (0 h) to successful vaginal delivery (4-7 h)
Indications of cesarean delivery
Time Frame: Analgesia initiation (0 h) to cesarean section (4-7 h)
Analgesia initiation (0 h) to cesarean section (4-7 h)
Maternal Visual Analog Scale (VAS) rating of pain
Time Frame: 15 min prior to analgesia, 0-3 h of the latent phrase, 2-3 h of the active phrase, 1-2 h of the second stage of labor, 15 min posterior to delivery
15 min prior to analgesia, 0-3 h of the latent phrase, 2-3 h of the active phrase, 1-2 h of the second stage of labor, 15 min posterior to delivery
Incidence of side effects
Time Frame: The whole period of the analgesia to successful vaginal delivery
The whole period of the analgesia to successful vaginal delivery
Low back pain at 3 months after vaginal delivery
Time Frame: Three months after vaginal delivery
Three months after vaginal delivery
Maternal oral temperature
Time Frame: The whole period of the analgesia to successful vaginal delivery
The whole period of the analgesia to successful vaginal delivery
Use of oxytocin after analgesia
Time Frame: During the whole period of the analgesia
During the whole period of the analgesia
Maximal oxytocin dose
Time Frame: 30 min after vaginal delivery
30 min after vaginal delivery
Duration of analgesia
Time Frame: Initiation of analgesia (0h) to the disappearance of sensory block (4-8h)
Initiation of analgesia (0h) to the disappearance of sensory block (4-8h)
Breastfeeding success at 6 weeks after vaginal delivery
Time Frame: Six weeks after successful delivery
Six weeks after successful delivery
Maternal satisfaction with analgesia
Time Frame: 30 min after the vaginal delivery
30 min after the vaginal delivery
Neonatal one-minute Apgar scale
Time Frame: One minute after baby was born
One minute after baby was born
Neonatal five-minute Apgar scale
Time Frame: Five minutes after baby was born
Five minutes after baby was born
Umbilical-cord gases analysis
Time Frame: Immediately after baby was born
Immediately after baby was born
Neonatal sepsis evaluation
Time Frame: 5 min after the baby was born
5 min after the baby was born
Neonatal antibiotic treatment
Time Frame: 5 min after the baby was born
5 min after the baby was born

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2008

Primary Completion (Actual)

May 1, 2009

Study Completion (Actual)

May 1, 2009

Study Registration Dates

First Submitted

April 18, 2008

First Submitted That Met QC Criteria

April 21, 2008

First Posted (Estimate)

April 22, 2008

Study Record Updates

Last Update Posted (Estimate)

May 27, 2009

Last Update Submitted That Met QC Criteria

May 26, 2009

Last Verified

May 1, 2009

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NMCHCH-0121-236
  • NMUC-08022

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Labor Pain

Clinical Trials on Doula combined analgesia

Subscribe